Literature DB >> 24321252

Allergen-induced production of IL-31 by canine Th2 cells and identification of immune, skin, and neuronal target cells.

Erin E McCandless1, Catherine A Rugg1, Gregory J Fici1, James E Messamore1, Michelle M Aleo1, Andrea J Gonzales2.   

Abstract

The canine cytokine IL-31 induces pruritus in dogs and can be detected in dogs with atopic dermatitis; however very little is understood around its interactions with specific canine cells. We hypothesize that IL-31 is involved in the progression of allergic skin disease by coordinating the interaction between the immune system with skin and neuronal systems. The goal of the following work was to identify cells that produce IL-31 as well as cells that may respond to this cytokine. Peripheral blood mononuclear cells (PBMCs) were collected from naïve and house dust mite (HDM) allergen-sensitized beagle dogs and used for ex vivo characterization of cytokine production assessed using ELISpot and quantitative immunoassay. Sensitization to HDM allergen induced a T-helper type 2 (Th2) cell phenotype characterized by an increase in the production of IL-4 protein. Interestingly, repeated allergen challenge over time also resulted in an increase in IFN-γ. Further evaluation showed that co-stimulation of Th2 polarized cells with antigen and the bacterial component Staphylococcus enterotoxin B (SEB) produced higher levels of IL-31 compared to either stimulant alone. Production of IL-31 when PBMCs were stimulated by T cell mitogens suggests T cells as a source of IL-31. Quantitative real-time PCR was utilized to determine expression of the IL-31 receptor alpha chain in canine cell lines and tissue. Canine monocytic cells, keratinocytes, and dorsal root ganglia were shown to express the IL-31 receptor alpha chain mRNA. In a multifaceted disease such as canine atopic dermatitis, the combination of Th2 polarization and microbial presence may lead to IL-31 mediated effects driving inflammation and pruritus by immune cells, keratinocytes, and direct neuronal stimulation.
Copyright © 2013 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Canine; Dorsal root ganglia; IL-31; Keratinocytes; Macrophages; Th2

Mesh:

Substances:

Year:  2013        PMID: 24321252     DOI: 10.1016/j.vetimm.2013.10.017

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  7 in total

1.  Atopic dermatitis in humans and dogs.

Authors:  Martín A Arcique; Jangi Bajwa
Journal:  Can Vet J       Date:  2020-01       Impact factor: 1.008

Review 2.  IL-31 Inhibition as a Therapeutic Approach for the Management of Chronic Pruritic Dermatoses.

Authors:  Youkyung S Roh; Justin Choi; Nishadh Sutaria; Micah Belzberg; Madan M Kwatra; Shawn G Kwatra
Journal:  Drugs       Date:  2021-04-21       Impact factor: 9.546

3.  Recombinant human interferon-α14 for the treatment of canine allergic pruritic disease in eight dogs.

Authors:  Breno C B Beirão; Aline C Taraciuk; Carolina Trentin; Max Ingberman; Luiz F Caron; Chris McKenzie; William H Stimson
Journal:  Vet Rec Open       Date:  2021-05-02

4.  Onset and duration of action of lokivetmab in a canine model of IL-31 induced pruritus.

Authors:  Timothy J Fleck; Lori R Norris; Sean Mahabir; Rodney R Walters; Olivier Martinon; Steven A Dunham; Andrea J Gonzales
Journal:  Vet Dermatol       Date:  2021-04-08       Impact factor: 1.867

Review 5.  Atopic dermatitis in cats and dogs: a difficult disease for animals and owners.

Authors:  Natalie Katharina Yvonne Gedon; Ralf Steffen Mueller
Journal:  Clin Transl Allergy       Date:  2018-10-05       Impact factor: 5.871

6.  Cannabinoid receptors in the inflammatory cells of canine atopic dermatitis.

Authors:  Roberto Chiocchetti; Giulia Salamanca; Margherita De Silva; Francesca Gobbo; Francesca Aspidi; Rodrigo Zamith Cunha; Giorgia Galiazzo; Claudio Tagliavia; Giuseppe Sarli; Maria Morini
Journal:  Front Vet Sci       Date:  2022-09-15

7.  IL-31-induced pruritus in dogs: a novel experimental model to evaluate anti-pruritic effects of canine therapeutics.

Authors:  Andrea J Gonzales; Timothy J Fleck; William R Humphrey; Betsy A Galvan; Michelle M Aleo; Sean P Mahabir; Jezaniah-Kira Tena; Karen G Greenwood; Robert B McCall
Journal:  Vet Dermatol       Date:  2015-12-15       Impact factor: 1.589

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.